Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Creighton

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Medicinal Chemistry|February 2, 1999
Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serumM J Kavarana, E G Kovaleva, D J Creighton, et al.
Biochemistry|October 16, 1999
Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogueA D Cameron, M Ridderström, B Olin, et al.
Journal of Medicinal Chemistry|May 29, 1999
A new method for rapidly generating inhibitors of glyoxalase I inside tumor cells using S-(N-aryl-N-hydroxycarbamoyl)ethylsulfoxidesD S Hamilton, M J Kavarana, E M Sharkey, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteinsS B Tencza, J P Douglass, D J Creighton, et al.
Journal of Medicinal Chemistry|July 8, 1994
S-(N-aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase IIN S Murthy, T Bakeris, M J Kavarana, et al.
Journal of Medicinal Chemistry|October 29, 2000
Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase IA Kalsi, M J Kavarana, T Lu, et al.
The Journal of Antimicrobial Chemotherapy|August 25, 1999
Lentivirus-derived antimicrobial peptides: increased potency by sequence engineering and dimerizationS B Tencza, D J Creighton, T Yuan, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase IE M Sharkey, H B O'Neill, M J Kavarana, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Medicinal Chemistry|February 2, 1999
Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serumM J Kavarana, E G Kovaleva, D J Creighton, et al.
Biochemistry|October 16, 1999
Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogueA D Cameron, M Ridderström, B Olin, et al.
Journal of Medicinal Chemistry|May 29, 1999
A new method for rapidly generating inhibitors of glyoxalase I inside tumor cells using S-(N-aryl-N-hydroxycarbamoyl)ethylsulfoxidesD S Hamilton, M J Kavarana, E M Sharkey, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteinsS B Tencza, J P Douglass, D J Creighton, et al.
Journal of Medicinal Chemistry|July 8, 1994
S-(N-aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase IIN S Murthy, T Bakeris, M J Kavarana, et al.
Journal of Medicinal Chemistry|October 29, 2000
Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase IA Kalsi, M J Kavarana, T Lu, et al.
The Journal of Antimicrobial Chemotherapy|August 25, 1999
Lentivirus-derived antimicrobial peptides: increased potency by sequence engineering and dimerizationS B Tencza, D J Creighton, T Yuan, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase IE M Sharkey, H B O'Neill, M J Kavarana, et al.
Pageof 4